• Study of Farletuzumab Ecteribulin for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France Spain

  • Study Comparing INBRX-101 and Human Alpha1-Proteinase Inhibitor for Adults with Alpha-1 Antitrypsin Deficiency Emphysema

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark Ireland Poland Spain Sweden

  • Study on Acalabrutinib for Very Old or Frail Patients with Chronic Lymphocytic Leukemia

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany

  • Study on the Effects of Navitoclax and Ruxolitinib for Patients with Myelofibrosis

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Croatia Greece Italy Spain

  • Study on the Effectiveness and Safety of Abatacept Biosimilar (DRL_AB) and Methotrexate for Patients with Moderate to Severe Rheumatoid Arthritis

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia Estonia Hungary Latvia Lithuania +2

  • Study of EPI-7386 and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Spain

  • Study of IPN01194 for Adults with Advanced Solid Tumors, Including Melanoma, Head and Neck Cancer, Pancreatic Cancer, and Colorectal Cancer

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France Spain

  • Study on the Long-Term Safety and Effectiveness of Losmapimod for Patients with Facioscapulohumeral Muscular Dystrophy (FSHD)

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France Spain

  • Study on the Effects of SAR443820 and Gadobutrol in Patients with Multiple Sclerosis

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria France Germany Italy Poland +1

  • Study of intravenous zanamivir safety and effectiveness in infants under 6 months of age with complicated influenza infection

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy Spain

powered by